1. Anti-inflammation (decrease IL-1β、IL-6、IL-8 via inhibiting the activation of NF-κB)2. Anti-Atherosclerosis (promote the expression of tRF-Glu-CTC-014)3. anti-platelet (directly blocks the thrombin catalytic site). The gene discussed is CXCL8; the disease is atherosclerosis.